Tighe Christopher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tighe Christopher has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Elia D. Tait Wojno
Department of Immunology, University of Washington, Seattle, WA, USA
2 shared publications - Alejandra Y. Lopez Espinoza
University of Washington School of Medicine, Seattle, WA, USA
1 shared publication - Alexis R. Gibson
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania
1 shared publication - Ankit Pandeya
Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA
1 shared publication - Bridget M. Mooney
University of Washington 3 Department of Immunology Seattle, WA
1 shared publication - Courtney E. McDougal
Department of Immunology, University of Washington, Seattle, WA, USA
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by Elsevier in Trends in Parasitology
- Vol. 42 (5) , 377-389
Environmental factors that regulate host–helminth interactions
- 14 April 2026
- Published by Elsevier in Trends in Parasitology
- Vol. 42 (5) , 377-389
Open AccessEnvironmental factors that regulate host–helminth interactions
- 13 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (6)
Enteric tuft cell inflammasome activation drives NKp46+ILC3 IL22 via PGD2 and inhibits Salmonella
To distinguish pathogens from commensals, the intestinal epithelium employs cytosolic innate immune sensors. Activation of the NAIP–NLRC4 inflammasome initiates extrusion of infected intestinal epithelial cells (IEC) upon cytosolic bacterial sensing. We previously reported that activation of the inflammasome in tuft cells, which are primarily known for their role in parasitic infections, leads to the release of prostaglandin D2 (PGD2). We observe that NAIP–NLRC4 inflammasome activation in tuft cells leads to an antibacterial response with increased IL-22 and antimicrobial protein levels within the small intestine, which is dependent on PGD2 signaling. A NKp46+ subset of ILC3 expresses the PGD2 receptor CRTH2 and is the source of the increased IL-22. Inflammasome activation in tuft cells also leads to better control of Salmonella Typhimurium in the distal small intestine. However, tuft cells in the cecum and colon are dispensable for antibacterial immunity. These data support that intestinal tuft cells can also induce antibacterial responses, possibly in a tissue-specific manner.
- 13 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (6)
Enteric tuft cell inflammasome activation drives NKp46+ILC3 IL22 via PGD2 and inhibits Salmonella
To distinguish pathogens from commensals, the intestinal epithelium employs cytosolic innate immune sensors. Activation of the NAIP–NLRC4 inflammasome initiates extrusion of infected intestinal epithelial cells (IEC) upon cytosolic bacterial sensing. We previously reported that activation of the inflammasome in tuft cells, which are primarily known for their role in parasitic infections, leads to the release of prostaglandin D2 (PGD2). We observe that NAIP–NLRC4 inflammasome activation in tuft cells leads to an antibacterial response with increased IL-22 and antimicrobial protein levels within the small intestine, which is dependent on PGD2 signaling. A NKp46+ subset of ILC3 expresses the PGD2 receptor CRTH2 and is the source of the increased IL-22. Inflammasome activation in tuft cells also leads to better control of Salmonella Typhimurium in the distal small intestine. However, tuft cells in the cecum and colon are dispensable for antibacterial immunity. These data support that intestinal tuft cells can also induce antibacterial responses, possibly in a tissue-specific manner.
- Open Access
- 23 September 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (9) , e1009493
Phagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes
Listeria monocytogenesis an intracellular bacterium that elicits robust CD8+T-cell responses. Despite the ongoing development ofL.monocytogenes-based platforms as cancer vaccines, our understanding of howL.monocytogenesdrives robust CD8+T-cell responses remains incomplete. One overarching hypothesis is that activation of cytosolic innate pathways is critical for immunity, as strains ofL.monocytogenesthat are unable to access the cytosol fail to elicit robust CD8+T-cell responses and in fact inhibit optimal T-cell priming. Counterintuitively, however, activation of known cytosolic pathways, such as the inflammasome and type I IFN, lead to impaired immunity. Conversely, production of prostaglandin E2(PGE2) downstream of cyclooxygenase-2 (COX-2) is essential for optimalL.monocytogenesT-cell priming. Here, we demonstrate that vacuole-constrainedL.monocytogeneselicit reduced PGE2production compared to wild-type strains in macrophages and dendritic cellsex vivo.In vivo, infection with wild-typeL.monocytogenesleads to 10-fold increases in PGE2production early during infection whereas vacuole-constrained strains fail to induce PGE2over mock-immunized controls. Mice deficient in COX-2 specifically in Lyz2+or CD11c+cells produce less PGE2, suggesting these cell subsets contribute to PGE2levelsin vivo, while depletion of phagocytes with clodronate abolishes PGE2production completely. Taken together, this work demonstrates that optimal PGE2production by phagocytes depends onL.monocytogenesaccess to the cytosol, suggesting that one reason cytosolic access is required to prime CD8+T-cell responses may be to facilitate production of PGE2.
- 23 September 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (9) , e1009493
Open AccessPhagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes
Listeria monocytogenesis an intracellular bacterium that elicits robust CD8+T-cell responses. Despite the ongoing development ofL.monocytogenes-based platforms as cancer vaccines, our understanding of howL.monocytogenesdrives robust CD8+T-cell responses remains incomplete. One overarching hypothesis is that activation of cytosolic innate pathways is critical for immunity, as strains ofL.monocytogenesthat are unable to access the cytosol fail to elicit robust CD8+T-cell responses and in fact inhibit optimal T-cell priming. Counterintuitively, however, activation of known cytosolic pathways, such as the inflammasome and type I IFN, lead to impaired immunity. Conversely, production of prostaglandin E2(PGE2) downstream of cyclooxygenase-2 (COX-2) is essential for optimalL.monocytogenesT-cell priming. Here, we demonstrate that vacuole-constrainedL.monocytogeneselicit reduced PGE2production compared to wild-type strains in macrophages and dendritic cellsex vivo.In vivo, infection with wild-typeL.monocytogenesleads to 10-fold increases in PGE2production early during infection whereas vacuole-constrained strains fail to induce PGE2over mock-immunized controls. Mice deficient in COX-2 specifically in Lyz2+or CD11c+cells produce less PGE2, suggesting these cell subsets contribute to PGE2levelsin vivo, while depletion of phagocytes with clodronate abolishes PGE2production completely. Taken together, this work demonstrates that optimal PGE2production by phagocytes depends onL.monocytogenesaccess to the cytosol, suggesting that one reason cytosolic access is required to prime CD8+T-cell responses may be to facilitate production of PGE2.